>Mercado de reactivos y dispositivos de inmunoensayo de Asia y el Pacífico, por producto (reactivos y kits, analizadores), plataforma (inmunoensayos de quimioluminiscencia, inmunoensayos de fluorescencia, inmunoensayos enzimáticos, radioinmunoensayos y otros), técnica (ensayos inmunoabsorbentes ligados a enzimas, pruebas rápidas, inmunospot ligado a enzimas, transferencia Western, inmuno-PCR y otras técnicas), tipo de muestra (sangre, orina, saliva y otras), aplicación (enfermedades infecciosas, oncología y endocrinología, trastornos óseos y minerales, cardiología, hematología y detección de sangre, trastornos autoinmunes, toxicología, detección neonatal y otras aplicaciones), usuario final (hospitales, laboratorios clínicos, empresas farmacéuticas y biotecnológicas, bancos de sangre, laboratorios de investigación y académicos y otros), país (China, Japón, India, Australia, Singapur, Indonesia, Tailandia, Corea del Sur, Malasia, Filipinas, resto de Asia-Pacífico) Tendencias de la industria y pronóstico hasta 2028.
Análisis y perspectivas del mercado: mercado de reactivos y dispositivos de inmunoensayo de Asia y el Pacífico
Se espera que el mercado de reactivos y dispositivos de inmunoensayo gane crecimiento de mercado en el período de pronóstico de 2021 a 2028. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 5,7% en el período de pronóstico de 2021 a 2028 y se espera que alcance los USD 9.737,46 millones para 2028. Se espera que la creciente prevalencia de enfermedades, que necesitan productos tecnológicamente avanzados para el diagnóstico para evitar malas interpretaciones, impulse el crecimiento del mercado de reactivos y dispositivos de inmunoensayo en el período de pronóstico.
Los inmunoensayos son pruebas que se realizan en laboratorios para detectar moléculas específicas. Básicamente, dependen de la capacidad integral del anticuerpo para unirse a la estructura particular de la molécula (antígeno) presente en la muestra. Los anticuerpos se producen dentro del cuerpo en respuesta a la presencia de antígeno en el mismo.
La aparición de la pandemia de COVID-19 ha provocado que la fabricación de pruebas de diagnóstico rápido (RDT) que utilizan técnicas de inmunoensayo actúen como un impulsor del crecimiento del mercado de reactivos y dispositivos de inmunoensayo. La retirada de productos tiene un impacto negativo, ya que los fabricantes invierten una cantidad significativa de dinero para reemplazar o reparar productos defectuosos, lo que a su vez da como resultado una disminución en la generación de ingresos. Por lo tanto, podría ser una restricción importante para el mercado de reactivos y dispositivos de inmunoensayo en el período de pronóstico. Se espera que el aumento en la investigación y el desarrollo en los reactivos y dispositivos de inmunoensayo con el fin de proporcionar productos mejorados o nuevos en el mercado cree una ventana de oportunidad para el crecimiento del mercado de reactivos y dispositivos de inmunoensayo en el período de pronóstico. Se espera que la presencia de la tecnología de cromatografía líquida-espectrometría de masas como método alternativo al inmunoensayo para detectar biomoléculas actúe como un desafío para el crecimiento del mercado de reactivos y dispositivos de inmunoensayo.
El informe de mercado de reactivos y dispositivos de inmunoensayo proporciona detalles de la participación de mercado, nuevos desarrollos y análisis de la cartera de productos, el impacto de los actores del mercado nacional y localizado, analiza las oportunidades en términos de bolsillos de ingresos emergentes, cambios en las regulaciones del mercado, aprobaciones de productos, decisiones estratégicas, lanzamientos de productos, expansiones geográficas e innovaciones tecnológicas en el mercado. Para comprender el análisis y el escenario del mercado de reactivos y dispositivos de inmunoensayo, comuníquese con Data Bridge Market Research para obtener un informe de analista; nuestro equipo lo ayudará a crear una solución de impacto en los ingresos para lograr su objetivo deseado.
Alcance y tamaño del mercado de reactivos y dispositivos de inmunoensayo
El mercado de reactivos y dispositivos de inmunoensayo está segmentado en función del producto, la plataforma, la técnica, el tipo de muestra, la aplicación y el usuario final. El crecimiento entre segmentos le ayuda a analizar nichos de crecimiento y estrategias para abordar el mercado y determinar sus áreas de aplicación principales y la diferencia en sus mercados objetivo.
- En función del producto, el mercado de reactivos y dispositivos de inmunoensayo se segmenta en reactivos y kits y analizadores. En 2021, el segmento de reactivos y kits domina debido a su mayor uso en el desarrollo de fármacos y en la detección de enfermedades.
- Sobre la base de la plataforma, el mercado de reactivos y dispositivos de inmunoensayo se segmenta en inmunoensayos de quimioluminiscencia, inmunoensayos de fluorescencia, inmunoensayos enzimáticos, inmunoensayos por radio y otros. En 2021, el segmento de inmunoensayos enzimáticos domina el mercado debido a sus ventajas, como la facilidad para realizar la prueba, los resultados precisos y muchos otros.
- En función de la técnica, el mercado de reactivos y dispositivos de inmunoensayo se segmenta en ensayos inmunoabsorbentes ligados a enzimas, pruebas rápidas, inmunoensayos inmunoabsorbentes ligados a enzimas, transferencia Western, PCR inmunológica y otras técnicas. En 2021, el segmento de ensayos inmunoabsorbentes ligados a enzimas es dominante porque es altamente sensible, fácil de realizar y ofrece resultados precisos para la detección de cualquier enfermedad o en el desarrollo de cualquier fármaco.
- Según el tipo de muestra, el mercado de reactivos y dispositivos de inmunoensayo se segmenta en saliva, orina, sangre y otros. En 2021, el segmento de sangre domina el mercado porque el antígeno se puede detectar fácilmente en la sangre.
- En función de la aplicación, el mercado de reactivos y dispositivos de inmunoensayo se segmenta en enfermedades infecciosas , oncología y endocrinología, trastornos óseos y minerales, cardiología, hematología y detección de sangre, trastornos autoinmunes, toxicología, detección neonatal y otras aplicaciones. En 2021, el segmento de oncología y endocrinología está dominando debido a la alta tasa de incidencia en todo el mundo que se puede detectar fácilmente con el uso de inmunoensayos.
- On the basis of end user, the immunoassay reagents and devices market is segmented into hospitals, clinical laboratories, pharmaceutical and biotechnology companies, blood banks, research & academic laboratories and others. In 2021, pharmaceutical and biotechnology companies segment is dominating the market because of high usage of immunoassays for the drug development.
Asia-Pacific Immunoassay Reagents and Devices Market Country Level Analysis
Asia-Pacific immunoassay reagents and devices market is analyzed and market size information is provided by the country, product, platform, technique, specimen type, application and end user as referenced above.
The countries covered in the Asia-Pacific immunoassay reagents and devices market report are the China, Japan, India, Australia, Singapore, Indonesia, Thailand, South Korea, Malaysia, Philippines and rest of Asia-Pacific.
China is leading the growth of the Asia-Pacific immunoassay reagents and devices market for platform segment due to presence of the highest number of immunoassay reagents and devices providers.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growing Strategic Activities by Major Market Players to enhance the Awareness for Immunoassay Reagents and Devices is boosting the Immunoassay Reagents and Devices Market
The immunoassay reagents and devices market also provides you with detailed immunoassay reagents and devices market analysis for every country growth in immunoassay reagents and devices market. Additionally, it provides the detailed information regarding the immunoassay reagents and devices market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.
Competitive Landscape and Immunoassay Reagents and Devices Market Share Analysis
El panorama competitivo del mercado de reactivos y dispositivos de inmunoensayo proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, los sitios e instalaciones de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, las líneas de prueba de productos, las aprobaciones de productos, las patentes, la amplitud y la extensión de los productos, el dominio de las aplicaciones y la curva de la línea de vida de la tecnología. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de la empresa relacionado con el mercado de reactivos y dispositivos de inmunoensayo de Asia-Pacífico.
Las principales empresas que participan en el informe de mercado de dispositivos y reactivos de inmunoensayo de Asia-Pacífico son F. Hoffmann-La Roche Ltd, Siemens, Randox Laboratories Ltd., Abbott, Bio-Rad Laboratories, Inc., Merck KGaA, Beckman Coulter, Inc. (una subsidiaria de Danaher), Sysmex Corporation, bioMérieux SA, Thermo Fisher Scientific, Inc., BD, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Ortho Clinical Diagnostics, QIAGEN, Quidel Corporation, BioCheck, Inc., Bio-Techne, PerkinElmer Inc., Agilent Technologies, Inc., Luminex Corporation, MESO SCALE DIAGNOSTICS, LLC, entre otros actores nacionales. Los analistas de DBMR comprenden las fortalezas competitivas y brindan un análisis competitivo para cada competidor por separado.
Numerosos contratos, acuerdos y lanzamientos son también iniciados por empresas de todo el mundo que también están acelerando el mercado de reactivos y dispositivos de inmunoensayo.
Por ejemplo,
- En julio de 2020, Bio-Rad Laboratories, Inc., líder mundial en investigación de ciencias biológicas y productos de diagnóstico clínico, anunció que la empresa lanzará un kit de inmunoensayo basado en sangre para identificar anticuerpos contra el coronavirus SARS-CoV-2, el virus asociado con la COVID-19. Se ha establecido el rendimiento preliminar del ensayo y el kit ahora se está evaluando clínicamente en varios hospitales para confirmar aún más el rendimiento clínico. Los datos iniciales recopilados en más de 700 muestras han demostrado una especificidad superior al 99 por ciento.
La colaboración, el lanzamiento de productos, la expansión comercial, los premios y reconocimientos, las empresas conjuntas y otras estrategias de los actores del mercado están mejorando la presencia de la empresa en el mercado de reactivos y dispositivos de inmunoensayo, lo que también brinda beneficios para el crecimiento de las ganancias de la organización.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 INDUSTRY INSIGHTS
5.1 NEW PRODUCT LAUNCHES:
5.2 REGULATIONS FOR IMMUNOASSAY REAGENT AND DEVICE MARKET –
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING INCIDENCE OF CHRONIC AND INFECTIOUS DISEASES
6.1.2 EMERGENCE OF COVID-19 PANDEMIC
6.1.3 WIDE APPLICATION OF IMMUNOASSAY
6.1.4 INCREASING HEALTHCARE EXPENDITURE
6.1.5 WIDE USE IN DRUG SCREENING TESTS
6.2 RESTRAINTS
6.2.1 HIGH COST OF IMMUNOASSAY KITS AND DEVICES
6.2.2 PRODUCT RECALL OF IMMUNOASSAY KITS AND DEVICES
6.3 OPPORTUNITIES
6.3.1 INCREASE IN RESEARCH & DEVELOPMENT ACTIVITIES
6.3.2 STRATEGIC INITATIVES BY THE COMPANIES
6.3.3 TECHNOLOGICAL UPGRADATION AND ADVANCEMENTS IN BIOTECHNOLOGY
6.4 CHALLENGES
6.4.1 AVAILABILITY OFALTERNATIVE TECHNOLOGIES
6.4.2 COMPLEXICITY IN PERFORMING IMMUNOASSAY
7 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 REAGENTS & KITS
7.2.1 ELISA REAGENTS & KITS
7.2.1.1 THIRD-GENERATION ELISA
7.2.1.2 FIFTH-GENERATION ELISA
7.2.1.3 FOURTH-GENERATION ELISA
7.2.1.4 FIRST-GENERATION ELISA
7.2.1.5 SECOND-GENERATION ELISA
7.2.2 ELISPOT REAGENTS & KITS
7.2.3 RAPID TEST REAGENTS & KITS
7.2.4 WESTERN BLOT REAGENTS & KITS
7.2.5 OTHER REAGENTS & KITS
7.3 ANALYZERS
7.3.1 BY TYPE
7.3.1.1 OPEN-ENDED SYSTEMS
7.3.1.2 CLOSED-ENDED SYSTEMS
7.3.2 BY DEVICE TYPE
7.3.2.1 BENCH-TOP
7.3.2.2 FLOOR STANDING
8 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM
8.1 OVERVIEW
8.2 ENZYME IMMUNOASSAY
8.3 FLUORESCENCE IMMUNOASSAYS
8.4 CHEMILUMINESCENCE IMMUNOASSAYS
8.5 RADIOIMMUNOASSAYS
8.6 OTHERS
9 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE
9.1 OVERVIEW
9.2 ENZYME-LINKED IMMUNOSORBENT ASSAYS
9.3 ENZYME-LINKED IMMUNOSPOT
9.4 RAPID TESTS
9.5 WESTERN BLOTTING
9.6 IMMUNO-PCR
9.7 OTHER TECHNIQUES
10 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE
10.1 OVERVIEW
10.2 BLOOD
10.3 URINE
10.4 SALIVA
10.5 OTHERS
11 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 ONCOLOGY AND ENDOCRINOLOGY
11.3 HEMATOLOGY & BLOOD SCREENING
11.4 CARDIOLOGY
11.5 INFECTIOUS DISEASES
11.6 BONE & MINERAL DISORDERS
11.7 AUTOIMMUNE DISORDERS
11.8 TOXICOLOGY
11.9 NEONATAL SCREENING
11.1 OTHER APPLICATIONS
12 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER
12.1 OVERVIEW
12.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
12.3 CLINICAL LABORATORIES
12.4 HOSPITALS
12.5 RESEARCH & ACADEMIC LABORATORIES
12.6 BLOOD BANKS
12.7 OTHERS
13 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY REGION
13.1 ASIA-PACIFIC
13.1.1 CHINA
13.1.2 JAPAN
13.1.3 INDIA
13.1.4 SOUTH KOREA
13.1.5 AUSTRALIA
13.1.6 MALAYSIA
13.1.7 SINGAPORE
13.1.8 THAILAND
13.1.9 INDONESIA
13.1.10 PHILIPPINES
13.1.11 REST OF ASIA-PACIFIC
14 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
15 COMPANY PROFILE
15.1 F. HOFFMANN-LA ROCHE LTD
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 ABBOTT
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 2.3 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 DIASORIN S.P.A
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 PERKINELMER INC.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 BIOMÉRIEUX SA
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENTS
15.6 AGILENT TECHNOLOGIES, INC.
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS
15.7 BD
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENTS
15.8 BECKMAN COULTER, INC (A SUBSIDIARY OF DANAHER)
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENTS
15.9 BIOCHECK, INC.
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.1 BIO-TECHNE
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENTS
15.11 BIO-RAD LABORATORIES, INC.
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENTS
15.12 LUMINEX CORPORATION
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENTS
15.13 MERCK KGAA
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENTS
15.14 MESO SCALE DIAGNOSTICS, LLC
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENTS
15.15 ORTHO CLINICAL DIAGNOSTICS
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENTS
15.16 QIAGEN
15.16.1 COMPANY SNAPSHOT
15.16.2 REVENUE ANALYSIS
15.16.3 PRODUCT PORTFOLIO
15.16.4 RECENT DEVELOPMENTS
15.17 QUIDEL CORPORATION
15.17.1 COMPANY SNAPSHOT
15.17.2 REVENUE ANALYSIS
15.17.3 PRODUCT PORTFOLIO
15.17.4 RECENT DEVELOPMENTS
15.18 RANDOX LABORATORIES LTD.
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENTS
15.19 SIEMENS
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENTS
15.2 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
15.20.1 COMPANY SNAPSHOT
15.20.2 REVENUE ANALYSIS
15.20.3 PRODUCT PORTFOLIO
15.20.4 RECENT DEVELOPMENTS
15.21 SYSMEX CORPORATION
15.21.1 COMPANY SNAPSHOT
15.21.2 REVENUE ANALYSIS
15.21.3 PRODUCT PORTFOLIO
15.21.4 RECENT DEVELOPMENTS
15.22 THERMO FISHER SCIENTIFIC INC.
15.22.1 COMPANY SNAPSHOT
15.22.2 REVENUE ANALYSIS
15.22.3 PRODUCT PORTFOLIO
15.22.4 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
Lista de Tablas
TABLE 1 COST OF ELISA KITS BY CELL SCIENCES, INC.
TABLE 2 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 3 ASIA PACIFIC REAGENTS AND KITS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 ASIA PACIFIC REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 5 ASIA PACIFIC ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 6 ASIA PACIFIC ANALYZERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA PACIFIC ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 8 ASIA PACIFIC ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 9 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 10 ASIA PACIFIC ENZYME IMMUNOASSAY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 ASIA PACIFIC FLUORESCENCE IMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 ASIA PACIFIC CHEMILUMINESCENCE IMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 ASIA PACIFIC RADIOIMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 ASIA PACIFIC OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 16 ASIA PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 ASIA PACIFIC ENZYME-LINKED IMMUNOSPOT IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 ASIA PACIFIC RAPID TESTS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 ASIA PACIFIC WESTERN BLOTTING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 ASIA PACIFIC IMMUNO-PCR IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 ASIA PACIFIC OTHER TECHNIQUES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 23 ASIA PACIFIC BLOOD IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA PACIFIC URINE IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 ASIA PACIFIC SALIVA IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA PACIFIC OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 28 ASIA PACIFIC ONCOLOGY AND ENDOCRINOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA PACIFIC HEMATOLOGY & BLOOD SCREENING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 ASIA PACIFIC CARDIOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 ASIA PACIFIC INFECTIOUS DISEASES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 ASIA PACIFIC BONE & MINERAL DISORDERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 ASIA PACIFIC AUTOIMMUNE DISORDERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 ASIA PACIFIC TOXICOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 ASIA PACIFIC NEONATAL SCREENING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 ASIA PACIFIC OTHER APPLICATIONS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 38 ASIA PACIFIC PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 ASIA PACIFIC CLINICAL LABORATORIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 40 ASIA PACIFIC HOSPITALS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 41 ASIA PACIFIC RESEARCH & ACADEMIC LABORATORIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 ASIA PACIFIC BLOOD BANKS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 43 ASIA PACIFIC OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 45 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 46 ASIA-PACIFIC ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 47 ASIA-PACIFIC ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 48 ASIA-PACIFIC REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 49 ASIA-PACIFIC ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 50 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 51 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 52 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 53 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 54 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 55 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 56 CHINA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 57 CHINA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 58 CHINA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 59 CHINA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 60 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 61 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 62 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 63 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 64 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 65 JAPAN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 66 JAPAN ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 67 JAPAN ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 68 JAPAN REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 69 JAPAN ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 70 JAPAN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 71 JAPAN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 72 JAPAN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 73 JAPAN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 74 JAPAN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 75 INDIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 76 INDIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 77 INDIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 78 INDIA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 79 INDIA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 80 INDIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 81 INDIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 82 INDIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 83 INDIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 84 INDIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 85 SOUTH KOREA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 86 SOUTH KOREA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 87 SOUTH KOREA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 88 SOUTH KOREA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 89 SOUTH KOREA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 90 SOUTH KOREA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 91 SOUTH KOREA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 92 SOUTH KOREA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 93 SOUTH KOREA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 94 SOUTH KOREA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 95 AUSTRALIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 96 AUSTRALIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 97 AUSTRALIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 98 AUSTRALIA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 99 AUSTRALIA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 100 AUSTRALIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 101 AUSTRALIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 102 AUSTRALIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 103 AUSTRALIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 104 AUSTRALIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 105 MALAYSIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 106 MALAYSIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 107 MALAYSIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 108 MALAYSIA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 109 MALAYSIA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 110 MALAYSIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 111 MALAYSIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 112 MALAYSIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 113 MALAYSIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 114 MALAYSIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 115 SINGAPORE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 116 SINGAPORE ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 117 SINGAPORE ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 118 SINGAPORE REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 119 SINGAPORE ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 120 SINGAPORE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 121 SINGAPORE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 122 SINGAPORE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 123 SINGAPORE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 124 SINGAPORE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 125 THAILAND IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 126 THAILAND ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 127 THAILAND ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 128 THAILAND REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 129 THAILAND ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 130 THAILAND IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 131 THAILAND IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 132 THAILAND IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 133 THAILAND IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 134 THAILAND IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 135 INDONESIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 136 INDONESIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 137 INDONESIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 138 INDONESIA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 139 INDONESIA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 140 INDONESIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 141 INDONESIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 142 INDONESIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 143 INDONESIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 144 INDONESIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 145 PHILIPPINES IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 146 PHILIPPINES ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 147 PHILIPPINES ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 148 PHILIPPINES REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 149 PHILIPPINES ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 150 PHILIPPINES IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 151 PHILIPPINES IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 152 PHILIPPINES IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 153 PHILIPPINES IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 154 PHILIPPINES IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 155 REST OF ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
Lista de figuras
FIGURE 1 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET : DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET : DROC ANALYSIS
FIGURE 4 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET : ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET : INTERVIEW DEMOGRAPHICS
FIGURE 8 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 NORTH AMERICA IS EXPECTED TO DOMINATE THE ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET AND GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 11 INCREASING HEALTHCARE EXPENDITURE IS EXPECTED TO DRIVE THE GROWTH OF THE ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 REAGENTS & KITS SEGMENT EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET
FIGURE 14 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT, 2020
FIGURE 15 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PLATFORM, 2020
FIGURE 16 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY TECHNIQUE, 2020
FIGURE 17 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY SPECIMEN TYPE, 2020
FIGURE 18 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY APPLICATION, 2020
FIGURE 19 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY END USER, 2020
FIGURE 20 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: SNAPSHOT (2020)
FIGURE 21 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2020)
FIGURE 22 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 23 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 24 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT (2021 & 2028)
FIGURE 25 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY SHARE 2020 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
